Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with high morbidity if untreated. Sometimes, despite aggressive treatments, the disease remains active with cumulative organic damage. We conducted a retrospective and descriptive observational study of patients with SLE...
- Autores:
-
Echeverri, Andrés Felipe
Cañas Dávila, Carlos Alberto
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2014
- Institución:
- Universidad ICESI
- Repositorio:
- Repositorio ICESI
- Idioma:
- eng
- OAI Identifier:
- oai:repository.icesi.edu.co:10906/78485
- Acceso en línea:
- http://www.scopus.com/inward/record.url?eid=2-s2.0-84893658088&partnerID=tZOtx3y1
http://hdl.handle.net/10906/78485
http://dx.doi.org/10.1155/2014/731806
- Palabra clave:
- Lupus eritematoso sistémico
Enfermedad Inflamatoria
Enfermedades autoinmunes
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc-nd/4.0/
| id |
ICESI2_4b20d12e3d73378078bc122e15e35632 |
|---|---|
| oai_identifier_str |
oai:repository.icesi.edu.co:10906/78485 |
| network_acronym_str |
ICESI2 |
| network_name_str |
Repositorio ICESI |
| repository_id_str |
|
| spelling |
Echeverri, Andrés FelipeCañas Dávila, Carlos AlbertoAmsterdam de Lat: 52 21 00 N degrees minutes Lat: 52.3500 decimal degrees Long: 004 55 00 E degrees minutes Long: 4.9167 decimal degrees2015-10-13T21:06:03Z2015-10-13T21:06:03Z2014-01-010896-8411http://www.scopus.com/inward/record.url?eid=2-s2.0-84893658088&partnerID=tZOtx3y1http://hdl.handle.net/10906/78485http://dx.doi.org/10.1155/2014/731806instname: Universidad Icesireponame: Biblioteca Digitalrepourl: https://repository.icesi.edu.co/Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with high morbidity if untreated. Sometimes, despite aggressive treatments, the disease remains active with cumulative organic damage. We conducted a retrospective and descriptive observational study of patients with SLE refractory to conventional treatment who were treated with rituximab (RTX) as remission induction therapy and maintenance. There was a significant reduction in the conventional immunosuppressive drug dose and the number of relapses of disease. RTX appeared to be effective and safe for the induction and maintenance of remission in patient with SLE refractory to conventional treatment. © 2014 Fabio Bonilla-Abadía et al.4 páginasDigitalapplication/pdfengElsevierÁmsterdamAutoimmune Diseases, Vo. 2014 - 2014EL AUTOR, expresa que la obra objeto de la presente autorización es original y la elaboró sin quebrantar ni suplantar los derechos de autor de terceros, y de tal forma, la obra es de su exclusiva autoría y tiene la titularidad sobre éste. PARÁGRAFO: en caso de queja o acción por parte de un tercero referente a los derechos de autor sobre el artículo, folleto o libro en cuestión, EL AUTOR, asumirá la responsabilidad total, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos, la Universidad Icesi actúa como un tercero de buena fe. Esta autorización, permite a la Universidad Icesi, de forma indefinida, para que en los términos establecidos en la Ley 23 de 1982, la Ley 44 de 1993, leyes y jurisprudencia vigente al respecto, haga publicación de este con fines educativos. Toda persona que consulte ya sea la biblioteca o en medio electrónico podrá copiar apartes del texto citando siempre la fuentes, es decir el título del trabajo y el autor.https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessAtribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)http://purl.org/coar/access_right/c_abf2Lupus eritematoso sistémicoEnfermedad InflamatoriaEnfermedades autoinmunesRituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosusinfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1Artículoinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85Comunidad Universidad Icesi – Investigadores201414ORIGINALecheverri_rituximab_remission_2014.pdfecheverri_rituximab_remission_2014.pdfapplication/pdf1238438http://repository.icesi.edu.co/biblioteca_digital/bitstream/10906/78485/1/echeverri_rituximab_remission_2014.pdf2bd59fd8be7aa7aeaadc9d84247af68fMD5110906/78485oai:repository.icesi.edu.co:10906/784852018-11-30 15:41:48.765Biblioteca Digital - Universidad icesicdcriollo@icesi.edu.co |
| dc.title.spa.fl_str_mv |
Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus |
| title |
Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus |
| spellingShingle |
Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus Lupus eritematoso sistémico Enfermedad Inflamatoria Enfermedades autoinmunes |
| title_short |
Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus |
| title_full |
Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus |
| title_fullStr |
Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus |
| title_full_unstemmed |
Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus |
| title_sort |
Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus |
| dc.creator.fl_str_mv |
Echeverri, Andrés Felipe Cañas Dávila, Carlos Alberto |
| dc.contributor.author.spa.fl_str_mv |
Echeverri, Andrés Felipe Cañas Dávila, Carlos Alberto |
| dc.subject.none.fl_str_mv |
Lupus eritematoso sistémico Enfermedad Inflamatoria Enfermedades autoinmunes |
| topic |
Lupus eritematoso sistémico Enfermedad Inflamatoria Enfermedades autoinmunes |
| description |
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with high morbidity if untreated. Sometimes, despite aggressive treatments, the disease remains active with cumulative organic damage. We conducted a retrospective and descriptive observational study of patients with SLE refractory to conventional treatment who were treated with rituximab (RTX) as remission induction therapy and maintenance. There was a significant reduction in the conventional immunosuppressive drug dose and the number of relapses of disease. RTX appeared to be effective and safe for the induction and maintenance of remission in patient with SLE refractory to conventional treatment. © 2014 Fabio Bonilla-Abadía et al. |
| publishDate |
2014 |
| dc.date.issued.none.fl_str_mv |
2014-01-01 |
| dc.date.accessioned.none.fl_str_mv |
2015-10-13T21:06:03Z |
| dc.date.available.none.fl_str_mv |
2015-10-13T21:06:03Z |
| dc.type.eng.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.local.spa.fl_str_mv |
Artículo |
| dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.coarversion.none.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| status_str |
publishedVersion |
| dc.identifier.issn.none.fl_str_mv |
0896-8411 |
| dc.identifier.other.spa.fl_str_mv |
http://www.scopus.com/inward/record.url?eid=2-s2.0-84893658088&partnerID=tZOtx3y1 |
| dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/10906/78485 |
| dc.identifier.doi.none.fl_str_mv |
http://dx.doi.org/10.1155/2014/731806 |
| dc.identifier.instname.none.fl_str_mv |
instname: Universidad Icesi |
| dc.identifier.reponame.none.fl_str_mv |
reponame: Biblioteca Digital |
| dc.identifier.repourl.none.fl_str_mv |
repourl: https://repository.icesi.edu.co/ |
| identifier_str_mv |
0896-8411 instname: Universidad Icesi reponame: Biblioteca Digital repourl: https://repository.icesi.edu.co/ |
| url |
http://www.scopus.com/inward/record.url?eid=2-s2.0-84893658088&partnerID=tZOtx3y1 http://hdl.handle.net/10906/78485 http://dx.doi.org/10.1155/2014/731806 |
| dc.language.iso.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartof.none.fl_str_mv |
Autoimmune Diseases, Vo. 2014 - 2014 |
| dc.rights.uri.none.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.license.none.fl_str_mv |
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) |
| dc.rights.coar.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.extent.none.fl_str_mv |
4 páginas |
| dc.format.medium.none.fl_str_mv |
Digital |
| dc.format.mimetype.none.fl_str_mv |
application/pdf |
| dc.coverage.spatial.none.fl_str_mv |
Amsterdam de Lat: 52 21 00 N degrees minutes Lat: 52.3500 decimal degrees Long: 004 55 00 E degrees minutes Long: 4.9167 decimal degrees |
| dc.publisher.none.fl_str_mv |
Elsevier |
| dc.publisher.place.none.fl_str_mv |
Ámsterdam |
| publisher.none.fl_str_mv |
Elsevier |
| institution |
Universidad ICESI |
| bitstream.url.fl_str_mv |
http://repository.icesi.edu.co/biblioteca_digital/bitstream/10906/78485/1/echeverri_rituximab_remission_2014.pdf |
| bitstream.checksum.fl_str_mv |
2bd59fd8be7aa7aeaadc9d84247af68f |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 |
| repository.name.fl_str_mv |
Biblioteca Digital - Universidad icesi |
| repository.mail.fl_str_mv |
cdcriollo@icesi.edu.co |
| _version_ |
1814094862018936832 |